Cell Medica raises £60M in series C

Cancer immunotherapy company Cell Medica Ltd. (London, U.K.) raised £60 million ($73.3 million) in a series C round. Existing investors Touchstone Innovations plc (LSE:IVO), Invesco Perpetual and Woodford Investment Management participated...